# RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus

> **NCT06724822** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Aqua Medical, Inc.** · enrollment: 12 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DEVICE:** RF Vapor Ablation

## Key facts

- **NCT ID:** NCT06724822
- **Lead sponsor:** Aqua Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06724822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06724822, "RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06724822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*